Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy.
about
Injected nanocrystals for targeted drug deliveryNanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinomaRational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice.Enhanced Antiproliferative Effect of Carboplatin in Cervical Cancer Cells Utilizing Folate-Grafted Polymeric Nanoparticles.In vivo biodistribution, biocompatibility, and efficacy of sorafenib-loaded lipid-based nanosuspensions evaluated experimentally in cancerHow nanotechnology can enhance docetaxel therapy.Salvianolic acid B protects against myocardial damage caused by nanocarrier TiO2; and synergistic anti-breast carcinoma effect with curcumin via codelivery system of folic acid-targeted and polyethylene glycol-modified TiO2 nanoparticlesSynergistic enhancement of cancer therapy using a combination of ceramide and docetaxel.Solid lipid nanoparticle formulations of docetaxel prepared with high melting point triglycerides: in vitro and in vivo evaluation.Folate-mediated chemotherapy and diagnostics: An updated review and outlook.Targeting nanomaterials: future drugs for cancer chemotherapy.Apatinib-loaded lipid nanobubbles combined with ultrasound-targeted nanobubble destruction for synergistic treatment of HepG2 cells in vitro
P2860
Q26752396-21D03149-0ED6-44C4-A1B8-D89A193F20F2Q26823523-FC7609B9-BEEC-469E-AB0D-C86456BB1716Q30436623-D6C68FAA-8321-4406-B628-B2856958298AQ36319751-2614CF4D-8B5D-4E9C-A9EC-0590FF3DCAF3Q36951503-A52F013A-ED05-45FD-B2F8-B80109D8CC4FQ37091683-A19E9520-11A1-4B90-8E5D-8A32BC553716Q37398335-E945C7D1-3624-40EC-818A-2C479AB0430BQ37684044-7B8C3FBF-9DDB-4743-A8E0-3FBFBBB33202Q37714256-7BF048D7-2DA2-4993-A9F4-91E6D613D07BQ39149880-9CE80303-B9AB-4FDE-99A7-6C2CFA595F31Q42417118-07FB8C82-8855-4EDD-BABE-4C45E37FDAC2Q58790284-D19A7FA3-092B-426D-B1CC-9CBFB7DB1061
P2860
Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy.
@ast
Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy.
@en
type
label
Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy.
@ast
Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy.
@en
prefLabel
Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy.
@ast
Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy.
@en
P2093
P2860
P356
P1476
Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy.
@en
P2093
P2860
P304
P356
10.2147/IJN.S32520
P407
P577
2012-06-29T00:00:00Z